Carine Delbrouck

Erasmus Hospital

Papers

2

Total Citations

21

H-Index

2

About

Carine Delbrouck is a leading neuro-otologist whose pioneering work focuses on the application of stereotactic radiosurgery for complex skull base tumors, particularly those affecting hearing and balance. Her major contributions center on refining Gamma Knife treatment for neurofibromatosis type 2 (NF2)-related vestibular schwannomas and the rare intralabyrinthine schwannomas. In her landmark 2013 study (12 citations), Delbrouck demonstrated that radiosurgery can achieve durable tumor control while preserving functional hearing in NF2 patients—a population notoriously difficult to treat without causing deafness. Her 2011 investigation (9 citations) was among the first to establish clear indications and technical protocols for Gamma Knife management of intralabyrinthine schwannomas, tumors arising within the cochlear and vestibular structures. By meticulously analyzing cranial nerve outcomes and hearing preservation rates, Delbrouck has provided critical evidence that minimally invasive radiosurgery can offer a safe alternative to microsurgical resection in carefully selected patients. Her work has directly influenced clinical guidelines for managing these challenging tumors, offering hope for maintaining quality of life through hearing conservation. Delbrouck’s research continues to shape the frontier of functional preservation in neuro-otologic radiosurgery.

Research Focus

Key Achievements

2
H-Index
2
Papers
21
Total Citations
11
Avg Citations/Paper
🏆 Most Cited Paper
Hearing preservation and tumour control after radiosurgery for NF2-related vestibular schwannomas.
12 citations · 2013
📈 Most Prolific Year: 2013 (1 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: Erasmus Hospital

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago